EXV-801/Dextromethorphan Hydrobromide

N/A

Report date: 2026/03/06 20:02:51
NME

Base Information

Drug NameEXV-801/Dextromethorphan Hydrobromide
Drug Alias NameEXV-801
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesUnited Kingdom
CombinationsYes EXV-801Dextromethorphan Hydrobromide
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesExciva GmbH
China Registration ClassN/A

Develop Information

Active CompaniesExciva GmbH
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A